The global market for allergy therapy is driven by an increase in the number of patients with various types of allergies, changing lifestyles, and environmental pollution. Some of the factors driving the growth of the global allergy treatment market include the rising number of patients with different allergies, including skin allergies, eye allergies, rhinitis, asthma, etc.; changes in dietary practices; rising demand for advanced therapy for allergy treatment; increasing research and development activities; and government initiatives. The global market for allergy treatment is, however, constrained by the high cost of immunotherapy for the treatment of allergies and its negative effects.
Allergy Treatment Market: Outlook
The immune system’s hypersensitivity to the environment, which often causes minor issues in most people, is the source of allergic disorders. Food allergy, allergic asthma, hay fever, atopic dermatitis, and anaphylaxis are among these allergic disorders. A runny nose, an itchy rash, shortness of breath, red eyes, swelling, and other symptoms are some of the signs of these allergic disorders.
Immunotherapy, avoiding triggers, and using antihistamines and steroids are a few methods used to manage such allergies. As opposed to countries that are more agricultural or traditional, allergy diseases are more prevalent in industrialized nations. It has also been observed that allergic disease rates are lower in rural than in urban people.
Allergy Treatment Market: Region-wise Outlook
The global market for allergy therapy is divided into seven major geographic regions based on geography: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, Middle East & Africa. Due to the rising number of patients with various types of allergies, including respiratory allergies, skin allergies, eye allergies, etc., North America and Europe are the two regions that lead the global market for allergy treatment.
Growing environmental pollution, a developed healthcare system, and a rise in the use of immunotherapy to treat allergies are all present in this area. Due to the region’s expanding allergic patient population, rising consumer awareness of available advanced immunotherapy for treating allergies, expanding healthcare infrastructure, and rising government spending in the healthcare sector, Asia-Pacific is the fastest-emerging market for allergy treatment globally.
Allergy Treatment Market: Key Players
Allergy Therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc., Sepracor, Inc., and Vicks are a few of the major market participants in the global allergy treatment market.
Companies that provide allergy treatment are currently merging and acquiring other businesses to grow their allergy treatment businesses. For instance, to grow its allergy immunotherapy business, Allergy Therapeutics purchased Alerpharma S.A. in June 2015. This Spanish company develops and currently offers allergy immunotherapy products and services.
Allergy Treatment Market: Segmentation
By Allergy Type
- Eye allergy
- Rhinitis
- Asthma
- Skin allergy
- Other Allergy
By Allergy Treatment Type
- Anti-allergy medicine
- Antihistamines
- Corticosteroids
- Decongestants
- Mast cell stabilizers
- Other medicines (Leukotriene, Calcineurin, Cromoglicate, Anti-IgE)
- Immunotherapy
By End User:
- Hospital
- Clinics
- Medical store
- Home use
- Others
